Lynnette C. Fallon
CIK: 0001195654
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- May 21, 2026CLPT
ClearPoint Neuro, Inc.
Award(A)DirectRestricted Stock Units
12.8K shares- - May 20, 2026CLPT
ClearPoint Neuro, Inc.
Sale(S)Direct5.1K shares at avg. $11.14$57K - May 19, 2026CLPT
ClearPoint Neuro, Inc.
Exercise(M)Direct12.4K shares- - Jun 3, 2025CLPT
ClearPoint Neuro, Inc.
Sale(S)Direct9K shares at avg. $12.53$113K - Jun 3, 2025CLPT
ClearPoint Neuro, Inc.
Sale(S)Direct1.2K shares at avg. $12.88$15K - May 22, 2025CLPT
ClearPoint Neuro, Inc.
Award(A)DirectRestricted Stock Units
12.4K shares- - May 16, 2025CLPT
ClearPoint Neuro, Inc.
Exercise(M)Direct21.1K shares- - Jan 3, 2025ACLS
AXCELIS TECHNOLOGIES INC
Tax Payment(F)Direct3.1K shares at avg. $71.96$222K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  CLPT ClearPoint Neuro, Inc. | Award(A) Restricted Stock Units | 12,820 | - | - | Direct |
| May 20, 2026 | CLPT ClearPoint Neuro, Inc. | Sale(S) | 5,091 | $11.14 | $56,714 | Direct |
| May 19, 2026 | CLPT ClearPoint Neuro, Inc. | Exercise(M) | 12,417 | - | $0 | Direct |
| Jun 3, 2025 | CLPT ClearPoint Neuro, Inc. | Sale(S) | 9,000 | $12.53 | $112,770 | Direct |
| Jun 3, 2025 | CLPT ClearPoint Neuro, Inc. | Sale(S) | 1,200 | $12.88 | $15,456 | Direct |
| May 22, 2025 | CLPT ClearPoint Neuro, Inc. | Award(A) Restricted Stock Units | 12,417 | - | - | Direct |
| May 16, 2025 | CLPT ClearPoint Neuro, Inc. | Exercise(M) | 21,093 | - | - | Direct |
| Jan 3, 2025 |  ACLS AXCELIS TECHNOLOGIES INC | Tax Payment(F) | 3,083 | $71.96 | $221,853 | Direct |
1-8 of 8 transactions
About FALLON LYNNETTE C
FALLON LYNNETTE C (SEC CIK 0001195654) files insider reports with the SEC as Director of ClearPoint Neuro, Inc. (CLPT) and EXECUTIVE VP, HR/LEGAL of AXCELIS TECHNOLOGIES INC (ACLS).
Signal8 holds 6 ownership filings by FALLON LYNNETTE C, all Form 4s, filed between Jan 7, 2025 and May 26, 2026. Those filings report 8 transactions, from Jan 3, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FALLON LYNNETTE C's filings is in BEVERLY, MA.
Recent filings by FALLON LYNNETTE C
- May 21, 2026: Grant or award of CLPT derivative securities (Form 4, code A).
- May 20, 2026: Open-market sale of CLPT shares (Form 4, code S).
- May 19, 2026: Option exercise of CLPT shares (Form 4, code M).
- Jun 3, 2025: Open-market sales of CLPT shares (2 lines, Form 4, code S).
- May 22, 2025: Grant or award of CLPT derivative securities (Form 4, code A).
Other insiders filing for ClearPoint Neuro, Inc. (CLPT)
- Richards Timothy T., Director
- FLETCHER R JOHN, Director
- BURNETT JOSEPH, CEO and President
- STIGALL L. JEREMY, Chief Business Officer
- D'Alessandro Danilo, Chief Financial Officer
- LIAU LINDA M., Director